• Canonical Anti-Apoptotic MCL-1 Function Drives Breast Cancer

  2026-06-26

  The reference study clarifies that breast cancer cells are reliant on the canonical anti-apoptotic activity of MCL-1, as genetic deletion or pharmacological inhibition of MCL-1 impedes tumor growth only when pro-apoptotic BAX/BAK are present. This evidence has direct implications for targeting MCL-1 in breast cancer and informs the use of selective MCL-1 inhibitors in experimental models.

• Metformin Hydrochloride: Mechanisms & Protocols in Metabolic

  2026-06-26

  Metformin Hydrochloride (Metformin HCl) is a validated AMPK signaling pathway modulator used in glucose metabolism and immunometabolic research. This dossier details its verifiable mechanisms—such as inhibition of hepatic gluconeogenesis and lipid biosynthesis attenuation—alongside actionable workflow parameters. The article clarifies boundaries for translational use and addresses common protocol pitfalls.

• Sabutoclax in Systems Oncology: Precision Tools for Function

  2026-06-25

  Explore how Sabutoclax, a potent pan-Bcl-2 inhibitor, enables functional apoptosis profiling and high-confidence translational oncology studies. This article uniquely analyzes in vitro assay interpretation, practical protocol design, and systems-level implications for cancer research.

• Anlotinib Hydrochloride in IADSRCT: Case Evidence and Resear

  2026-06-25

  This article reviews a landmark report on anlotinib hydrochloride as a multi-target tyrosine kinase inhibitor in the management of intra-abdominal desmoplastic small round cell tumors (IADSRCT), a rare and aggressive malignancy. The paper provides the first clinical evidence of anlotinib's efficacy in IADSRCT, highlighting both response and tolerability, with implications for further research in anti-angiogenic strategies for difficult-to-treat tumors.

• NAT10-Driven ac4C RNA Modification Regulates Mouse Oocyte Ma

  2026-06-24

  This study provides the first mechanistic evidence that NAT10-mediated N4-acetylcytidine (ac4C) RNA modification is a key regulator of post-transcriptional gene expression during mouse oocyte maturation in vitro. The work uncovers how ac4C dynamics and NAT10 levels influence meiotic progression, identifying TBL3 as a candidate ac4C-binding protein and highlighting novel targets for improving oocyte developmental competence.

• Preclinical Characterization of Anlotinib: Potent Angiogenes

  2026-06-23

  The reference study establishes anlotinib hydrochloride as a highly selective and potent inhibitor of VEGFR2, with significant anti-angiogenic activity in preclinical cancer models. These findings highlight anlotinib's promise as a multi-target tyrosine kinase inhibitor for advanced cancer research, particularly where endothelial cell migration and angiogenesis are central.

• ABT-737: BCL-2 Protein Inhibitor for Apoptosis in Cancer Res

  2026-06-23

  ABT-737 delivers targeted apoptosis induction in cancer cells, enabling mechanistic and translational breakthroughs in oncology research. This guide covers optimized workflows, troubleshooting, and novel insights from recent senolytic studies to help researchers maximize the impact of ABT-737 in complex experimental settings.

• ABT-737 (SKU A8193): Empowering Reliable Apoptosis Assays

  2026-06-22

  This article guides biomedical researchers through common laboratory challenges in apoptosis and cytotoxicity assays, focusing on the scientific and workflow benefits of ABT-737 (SKU A8193). Scenario-driven Q&A blocks offer evidence-based solutions, highlighting APExBIO’s product quality and data-backed performance in cancer research, including lymphoma, multiple myeloma, SCLC, and AML applications.

• Calpeptin in Fibrosis & Cell Death: Mechanistic Insights for

  2026-06-22

  Explore the mechanistic depth of Calpeptin as a calpain inhibitor in fibrosis and apoptosis research. This article uniquely bridges molecular cell death pathways and practical assay design, empowering advanced fibrosis and inflammation studies.

• Phosphatase Inhibitor Cocktail 3: Precision in Phosphoprotei

  2026-06-21

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) delivers robust serine/threonine phosphatase inhibition, empowering researchers to preserve delicate phosphorylation states during protein extraction and analysis. Its broad-spectrum efficacy and compatibility with advanced workflows set a new standard for reproducible phosphoprotein studies.

• Phosbind Acrylamide: Advancing Phosphorylation Analysis Work

  2026-06-20

  Phosbind Acrylamide enables rapid, antibody-free differentiation of phosphorylated proteins by SDS-PAGE, streamlining signal transduction research. Its high specificity and compatibility with physiological pH empower researchers to dissect phosphorylation events in stress responses and kinase assays with unmatched clarity.

• Exendin-4 (Exenatide): Applied Workflows in Diabetes Researc

  2026-06-19

  Explore how Exendin-4 (Exenatide) empowers researchers to model insulin sensitivity, beta cell function, and hepatic steatosis reversal in translational type 2 diabetes studies. This guide distills latest recombinant production advances, actionable protocols, troubleshooting tips, and real-world workflow optimizations.

• LDH Cytotoxicity Assay Kit: Next-Gen Biocompatibility Insigh

  2026-06-19

  Discover how the LDH Cytotoxicity Assay Kit advances cell cytotoxicity measurement, enabling deeper biocompatibility analysis for nanomaterials and disease models. This article reveals practical, evidence-based strategies for unlocking high-sensitivity, non-radioactive workflows.

• Dextrose (D-glucose) in Advanced Glucose Metabolism Research

  2026-06-18

  Dextrose (D-glucose) from APExBIO empowers high-precision modeling of metabolic reprogramming in hypoxia and immunometabolic studies. With robust solubility and validated purity, it is the go-to substrate for reproducible cell-based and translational workflows.

• Porous Graphene Films Enable High-Resolution MSI of Ethanol-

  2026-06-18

  This study presents laser-induced graphene (LIG) as a novel substrate for laser desorption/ionization mass spectrometry imaging (LDI-MSI). By overcoming matrix-related limitations, the method achieves 3-μm spatial resolution, revealing dynamic spatial and temporal metabolic asymmetry in mouse brain lipids after ethanol exposure.

16068 records 1/1072 page Next 12345 下5页 Last page